$CMRX
CHIMERIX INC

2015 Q2 Form 10-Q Financial Statement

#000111748015000012 Filed on May 11, 2015

View on sec.gov

Income Statement

Concept 2015 Q2 2015 Q1 2014 Q1
Revenue $4.143M $1.238M $780.0K
YoY Change 350.82% 58.72% -55.96%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $7.332M $6.123M $2.672M
YoY Change 65.77% 129.15% 73.51%
% of Gross Profit
Research & Development $21.86M $17.44M $8.292M
YoY Change 170.14% 110.37% 22.3%
% of Gross Profit
Depreciation & Amortization $150.0K $114.0K $50.00K
YoY Change 200.0% 128.0% -28.57%
% of Gross Profit
Operating Expenses $29.09M $23.57M $10.96M
YoY Change 132.47% 114.95% 31.78%
Operating Profit -$24.95M -$22.33M -$10.18M
YoY Change 115.17% 119.26% 55.53%
Interest Expense $140.0K $60.00K -$200.0K
YoY Change -200.0% -130.0% -44.44%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$24.82M -$22.27M -$10.38M
YoY Change 111.59% 114.55% 13.94%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$24.82M -$22.27M -$10.38M
YoY Change 111.48% 114.51% 13.98%
Net Earnings / Revenue -598.96% -1798.55% -1330.77%
Basic Earnings Per Share
Diluted Earnings Per Share -$589.8K -$532.1K -$387.9K
COMMON SHARES
Basic Shares Outstanding 41.32M shares 41.09M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q2 2015 Q1 2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $258.3M $174.5M $99.90M
YoY Change 28.76% 74.67% 336.24%
Cash & Equivalents $127.8M $55.61M $37.42M
Short-Term Investments $130.6M $118.9M $62.50M
Other Short-Term Assets $8.700M $1.800M $1.400M
YoY Change 171.88% 28.57% -17.65%
Inventory
Prepaid Expenses
Receivables $2.311M $977.0K $100.0K
Other Receivables $0.00 $0.00 $300.0K
Total Short-Term Assets $269.3M $177.3M $101.7M
YoY Change 31.88% 74.3% 292.66%
LONG-TERM ASSETS
Property, Plant & Equipment $1.996M $1.329M $400.0K
YoY Change 299.2% 232.25% 0.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $150.1M $95.20M
YoY Change
Other Assets $80.00K $297.0K $0.00
YoY Change -100.0%
Total Long-Term Assets $152.2M $96.87M $500.0K
YoY Change 30343.0% 19273.0% 25.0%
TOTAL ASSETS
Total Short-Term Assets $269.3M $177.3M $101.7M
Total Long-Term Assets $152.2M $96.87M $500.0K
Total Assets $421.5M $274.1M $102.2M
YoY Change 105.91% 168.22% 288.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.819M $6.920M $1.800M
YoY Change 216.74% 284.44% -33.33%
Accrued Expenses $10.76M $6.630M $1.900M
YoY Change 198.83% 248.95% 11.76%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.500M $2.900M $5.600M
YoY Change -73.21% -48.21% 1.82%
Total Short-Term Liabilities $22.06M $16.44M $9.300M
YoY Change 80.83% 76.8% -6.06%
LONG-TERM LIABILITIES
Long-Term Debt $100.0K $200.0K $2.900M
YoY Change -93.33% -93.1% -65.88%
Other Long-Term Liabilities $134.0K $161.0K $400.0K
YoY Change -55.33% -59.75% -96.04%
Total Long-Term Liabilities $134.0K $161.0K $3.300M
YoY Change -92.56% -95.12% -82.26%
TOTAL LIABILITIES
Total Short-Term Liabilities $22.06M $16.44M $9.300M
Total Long-Term Liabilities $134.0K $161.0K $3.300M
Total Liabilities $22.20M $16.60M $12.50M
YoY Change 58.54% 32.82% -56.14%
SHAREHOLDERS EQUITY
Retained Earnings -$269.1M -$244.3M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $399.3M $257.5M $89.60M
YoY Change
Total Liabilities & Shareholders Equity $421.5M $274.1M $102.2M
YoY Change 105.91% 168.22% 288.59%

Cashflow Statement

Concept 2015 Q2 2015 Q1 2014 Q1
OPERATING ACTIVITIES
Net Income -$24.82M -$22.27M -$10.38M
YoY Change 111.48% 114.51% 13.98%
Depreciation, Depletion And Amortization $150.0K $114.0K $50.00K
YoY Change 200.0% 128.0% -28.57%
Cash From Operating Activities -$23.02M -$18.84M -$9.116M
YoY Change 139.04% 106.66% 50.68%
INVESTING ACTIVITIES
Capital Expenditures -$820.0K $133.0K $99.00K
YoY Change 530.77% 34.34% -298.0%
Acquisitions
YoY Change
Other Investing Activities -$65.16M -$54.59M -$62.64M
YoY Change 247.33% -12.85% 5594.55%
Cash From Investing Activities -$65.98M -$54.72M -$62.74M
YoY Change 249.29% -12.78% 5308.53%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 161.2M $701.0K -$700.0K
YoY Change 45.58% -200.14% 4.48%
NET CHANGE
Cash From Operating Activities -23.02M -$18.84M -$9.116M
Cash From Investing Activities -65.98M -$54.72M -$62.74M
Cash From Financing Activities 161.2M $701.0K -$700.0K
Net Change In Cash 72.17M -$72.86M -$72.56M
YoY Change -12.19% 0.42% 820.75%
FREE CASH FLOW
Cash From Operating Activities -$23.02M -$18.84M -$9.116M
Capital Expenditures -$820.0K $133.0K $99.00K
Free Cash Flow -$22.20M -$18.97M -$9.215M
YoY Change 133.68% 105.88% 53.58%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q1 cmrx Availablefor Sale Securities Debt Maturities Year Onethrough Two Fair Value
AvailableforSaleSecuritiesDebtMaturitiesYearOnethroughTwoFairValue
95239000 USD
CY2015Q1 dei Amendment Flag
AmendmentFlag
false
CY2015Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2015Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2015Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2015Q1 dei Document Period End Date
DocumentPeriodEndDate
2015-03-31
CY2015Q1 dei Document Type
DocumentType
10-Q
CY2015Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001117480
CY2015Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
41316704 shares
CY2015Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2015Q1 dei Entity Registrant Name
EntityRegistrantName
CHIMERIX INC
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5938000 USD
CY2015Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
6920000 USD
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
106000 USD
CY2015Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
977000 USD
CY2014Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-108000 USD
CY2015Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-425000 USD
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6833000 USD
CY2015Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6630000 USD
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
35000 USD
CY2015Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
659000 USD
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
496602000 USD
CY2015Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
501130000 USD
CY2014Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
772000 USD
CY2015Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2402000 USD
CY2014Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
42000 USD
CY2015Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
26000 USD
CY2014Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2645620 shares
CY2015Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1408852 shares
CY2014Q4 us-gaap Assets
Assets
291878000 USD
CY2015Q1 us-gaap Assets
Assets
274125000 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
237457000 USD
CY2015Q1 us-gaap Assets Current
AssetsCurrent
177260000 USD
CY2014Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
159087000 USD
CY2015Q1 us-gaap Available For Sale Securities
AvailableForSaleSecurities
214137000 USD
CY2014Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
237000 USD
CY2015Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
997000 USD
CY2014Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
202000 USD
CY2015Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
74000 USD
CY2014Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
159052000 USD
CY2015Q1 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
213214000 USD
CY2014Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
106114000 USD
CY2015Q1 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
118898000 USD
CY2015Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
118898000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
109976000 USD
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
37421000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
128462000 USD
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
55605000 USD
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-72555000 USD
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-72857000 USD
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2015Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2015Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
41031770 shares
CY2015Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
41310063 shares
CY2014Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
41000 USD
CY2015Q1 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
41000 USD
CY2014Q1 us-gaap Contracts Revenue
ContractsRevenue
780000 USD
CY2015Q1 us-gaap Contracts Revenue
ContractsRevenue
1238000 USD
CY2014Q1 us-gaap Depreciation
Depreciation
50000 USD
CY2015Q1 us-gaap Depreciation
Depreciation
114000 USD
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.39
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.54
CY2015Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.00
CY2014Q4 us-gaap Fair Value Assumptions Exercise Price
FairValueAssumptionsExercisePrice
2.22
CY2015Q1 us-gaap Fair Value Assumptions Exercise Price
FairValueAssumptionsExercisePrice
3.08
CY2014Q4 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0
CY2015Q1 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0
CY2014Q4 us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P1Y6M
CY2015Q1 us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P1Y2M19D
CY2014 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.65
CY2015Q1 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.65
CY2014 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0044
CY2015Q1 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0026
CY2014Q4 us-gaap Fair Value Inputs Discount For Lack Of Marketability
FairValueInputsDiscountForLackOfMarketability
0.25
CY2015Q1 us-gaap Fair Value Inputs Discount For Lack Of Marketability
FairValueInputsDiscountForLackOfMarketability
0.24
us-gaap Fair Value Investments Entities That Calculate Net Asset Value Per Share Redemption Restriction Period
FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareRedemptionRestrictionPeriod
P18M
CY2014Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-934000 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
511000 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-159000 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
871000 USD
CY2014Q1 us-gaap Increase Decrease In Deferred Leasing Fees
IncreaseDecreaseInDeferredLeasingFees
-3000 USD
CY2014Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1064000 USD
CY2015Q1 us-gaap Increase Decrease In Deferred Leasing Fees
IncreaseDecreaseInDeferredLeasingFees
12000 USD
CY2015Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-832000 USD
CY2015Q1 us-gaap Liabilities
Liabilities
16603000 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
291878000 USD
CY2015Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
274125000 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
17067000 USD
CY2014Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-196000 USD
CY2015Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
63000 USD
CY2014Q1 us-gaap Interest Paid Net
InterestPaidNet
198000 USD
CY2015Q1 us-gaap Interest Paid Net
InterestPaidNet
70000 USD
CY2014Q4 us-gaap Liabilities
Liabilities
17242000 USD
CY2015Q1 us-gaap Liabilities Current
LiabilitiesCurrent
16442000 USD
CY2012Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
15000000 USD
CY2014Q4 us-gaap Loans Payable Current
LoansPayableCurrent
4296000 USD
CY2015Q1 us-gaap Loans Payable Current
LoansPayableCurrent
2892000 USD
CY2014Q4 us-gaap Long Term Investments
LongTermInvestments
52973000 USD
CY2015Q1 us-gaap Long Term Investments
LongTermInvestments
95239000 USD
CY2014Q1 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-32000 USD
CY2015Q1 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
625000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-700000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
701000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-62739000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-54719000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9116000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18839000 USD
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-10184000 USD
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-22329000 USD
CY2014Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
100000 USD
CY2015Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
200000 USD
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
138000 USD
CY2015Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
297000 USD
CY2014Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-10412000 USD
CY2015Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-21641000 USD
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
175000 USD
CY2015Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
161000 USD
CY2014Q1 us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
0 USD
CY2015Q1 us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
65232000 USD
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
99000 USD
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
133000 USD
CY2014Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
62640000 USD
CY2015Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
26709000 USD
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2015Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2015Q1 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2775000 USD
CY2015Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1780000 USD
CY2014Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
229000 USD
CY2015Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
461000 USD
CY2014Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
0 USD
CY2015Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
36352000 USD
CY2014Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
0 USD
CY2015Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
1003000 USD
CY2014Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
496000 USD
CY2015Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
665000 USD
CY2014Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 USD
CY2015Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1000000 USD
CY2014Q1 us-gaap Profit Loss
ProfitLoss
-10380000 USD
CY2015Q1 us-gaap Profit Loss
ProfitLoss
-22266000 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1310000 USD
CY2015Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1329000 USD
CY2014Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
1425000 USD
CY2015Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
1425000 USD
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8292000 USD
CY2015Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17444000 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-222042000 USD
CY2015Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-244308000 USD
CY2014Q1 us-gaap Revenues
Revenues
780000 USD
CY2015Q1 us-gaap Revenues
Revenues
1238000 USD
CY2014Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2672000 USD
CY2015Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6123000 USD
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
772000 USD
CY2015Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2402000 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
274636000 USD
CY2015Q1 us-gaap Stockholders Equity
StockholdersEquity
257522000 USD
CY2014Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
26762264 shares
CY2015Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
41220989 shares

Files In Submission

Name View Source Status
0001117480-15-000012-index-headers.html Edgar Link pending
0001117480-15-000012-index.html Edgar Link pending
0001117480-15-000012.txt Edgar Link pending
0001117480-15-000012-xbrl.zip Edgar Link pending
a20150331cmrx10-qdocument.htm Edgar Link pending
a20150331cmrxex-102.htm Edgar Link pending
a20150331cmrxex-103.htm Edgar Link pending
a20150331cmrxex-311.htm Edgar Link pending
a20150331cmrxex-312.htm Edgar Link pending
a20150331cmrxex-321.htm Edgar Link pending
a20150331cmrxex-322.htm Edgar Link pending
chimerixnotary1.jpg Edgar Link pending
chimerixnotary2.jpg Edgar Link pending
chimerixsignature.jpg Edgar Link pending
chimerixsignature2.jpg Edgar Link pending
chimerixsignature2a01.jpg Edgar Link pending
chimerixsignature2a02.jpg Edgar Link pending
cmrx-20150331.xml Edgar Link completed
cmrx-20150331.xsd Edgar Link pending
cmrx-20150331_cal.xml Edgar Link unprocessable
cmrx-20150331_def.xml Edgar Link unprocessable
cmrx-20150331_lab.xml Edgar Link unprocessable
cmrx-20150331_pre.xml Edgar Link unprocessable
exhibita.jpg Edgar Link pending
exhibita1.jpg Edgar Link pending
exhibita2.jpg Edgar Link pending
exhibita3.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ivcmeridiannotary.jpg Edgar Link pending
ivcmeridianttollcsignature.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending